0000899243-20-033216.txt : 20201209
0000899243-20-033216.hdr.sgml : 20201209
20201209200009
ACCESSION NUMBER: 0000899243-20-033216
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201207
FILED AS OF DATE: 20201209
DATE AS OF CHANGE: 20201209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Snyder Douglas B.
CENTRAL INDEX KEY: 0001754125
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35892
FILM NUMBER: 201379118
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB249BZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001351288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
BUSINESS PHONE: 44 1223 266800
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-07
0
0001351288
GW PHARMACEUTICALS PLC
GWPH
0001754125
Snyder Douglas B.
SOVEREIGN HOUSE, VISION PARK, HISTON
CAMBRIDGE
X0
CB24 9BZ
UNITED KINGDOM
0
1
0
0
Chief Legal Officer
Ordinary Shares
2020-12-07
4
S
0
4800
10.84
D
22104
D
Ordinary Shares
2020-12-07
4
S
0
9444
10.95
D
23660
D
Ordinary Shares
2020-12-07
4
S
0
3984
11.02
D
8676
D
Ordinary Shares
2020-12-07
4
S
0
5076
11.11
D
3600
D
Ordinary Shares
2020-12-07
4
S
0
1200
11.19
D
2400
D
Ordinary Shares
2020-12-07
4
S
0
2400
11.30
D
0
D
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2020.
Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($130.0325 per ADS). These shares were sold in multiple transactions at prices ranging from $129.69 per ADS (or $10.81 per ordinary share) to $130.50 per ADS (or $10.88 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($131.3749 per ADS). These shares were sold in multiple transactions at prices ranging from $130.83 per ADS (or $10.90 per ordinary share) to $131.81 per ADS (or $10.98 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($132.2066 per ADS). These shares were sold in multiple transactions at prices ranging from $131.87 per ADS (or $10.99 per ordinary share) to $132.30 per ADS (or $11.03 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($133.2948 per ADS). These shares were sold in multiple transactions at prices ranging from $132.90 per ADS (or $11.08 per ordinary share) to $133.64 per ADS (or $11.14 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($134.3200 per ADS). These shares were sold in multiple transactions at prices ranging from $134.32 per ADS (or $11.19 per ordinary share) to $134.32 per ADS (or $11.19 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($135.6500 per ADS). These shares were sold in multiple transactions at prices ranging from $135.65 per ADS (or $11.30 per ordinary share) to $135.65 per ADS (or $11.30 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Douglas B. Snyder
2020-12-09